Skip to Main Content

Author Details

Val??rie Petit
INSERM U1021, Institut Curie, PSL Research University, Campus Universitaire
1999
45
21
PMIDPaper TitleJournal TitlePublished Year
37739336Loss of Dicer in Newborn Melanocytes Leads to Premature Hair Graying and Changes in Integrin Expression.J Invest Dermatol2024
37739336Loss of Dicer in Newborn Melanocytes Leads to Premature Hair Graying and Changes in Integrin Expression.J Invest Dermatol2024
36958885Derivation and Use of Cell Lines from Mouse Models of Melanoma.J Invest Dermatol2023
36958885Derivation and Use of Cell Lines from Mouse Models of Melanoma.J Invest Dermatol2023
34310951CLEC12B Decreases Melanoma Proliferation by Repressing Signal Transducer and Activator of Transcription 3.J Invest Dermatol2022
34310951CLEC12B Decreases Melanoma Proliferation by Repressing Signal Transducer and Activator of Transcription 3.J Invest Dermatol2022
34140478BRN2 is a non-canonical melanoma tumor-suppressor.Nat Commun2021
33804655Efficacy of Targeted Radionuclide Therapy Using [<sup>131</sup>I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant Melanoma.Cancers (Basel)2021
34140478BRN2 is a non-canonical melanoma tumor-suppressor.Nat Commun2021
33804655Efficacy of Targeted Radionuclide Therapy Using [<sup>131</sup>I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant Melanoma.Cancers (Basel)2021
30538121TET2-Dependent Hydroxymethylome Plasticity Reduces Melanoma Initiation and Progression.Cancer Res2019
30538121TET2-Dependent Hydroxymethylome Plasticity Reduces Melanoma Initiation and Progression.Cancer Res2019
31251472C57BL/6 congenic mouse NRAS<sup>Q61K</sup> melanoma cell lines are highly sensitive to the combination of Mek and Akt inhibitors in vitro and in vivo.Pigment Cell Melanoma Res2019
31515603Modeling and analysis of melanoblast motion.J Math Biol2019
31515603Modeling and analysis of melanoblast motion.J Math Biol2019
31251472C57BL/6 congenic mouse NRAS<sup>Q61K</sup> melanoma cell lines are highly sensitive to the combination of Mek and Akt inhibitors in vitro and in vivo.Pigment Cell Melanoma Res2019
29769218Simulation of melanoblast displacements reveals new features of developmental migration.Development2018
29769218Simulation of melanoblast displacements reveals new features of developmental migration.Development2018
27775073p53 deficiency induces cancer stem cell pool expansion in a mouse model of triple-negative breast tumors.Oncogene2017
28651696Importance of the regiospecific distribution of long-chain saturated fatty acids on gut comfort, fat and calcium absorption in infants.Prostaglandins Leukot Essent Fatty Acids2017
27775073p53 deficiency induces cancer stem cell pool expansion in a mouse model of triple-negative breast tumors.Oncogene2017
28191677UVB represses melanocyte cell migration and acts through β-catenin.Exp Dermatol2017
28191677UVB represses melanocyte cell migration and acts through β-catenin.Exp Dermatol2017
28651696Importance of the regiospecific distribution of long-chain saturated fatty acids on gut comfort, fat and calcium absorption in infants.Prostaglandins Leukot Essent Fatty Acids2017
27119971Any route for melanoblasts to colonize the skin!Exp Dermatol2016
27119971Any route for melanoblasts to colonize the skin!Exp Dermatol2016
27734546Letter: evidence of gut-to-brain and brain-to-gut pathways in the pathogenesis of functional gastrointestinal disorders - 'first-ever' incidence would be needed to draw conclusions.Aliment Pharmacol Ther2016
27537685Tyrosinase-Cre-Mediated Deletion of the Autophagy Gene Atg7 Leads to Accumulation of the RPE65 Variant M450 in the Retinal Pigment Epithelium of C57BL/6 Mice.PLoS One2016
27734546Letter: evidence of gut-to-brain and brain-to-gut pathways in the pathogenesis of functional gastrointestinal disorders - 'first-ever' incidence would be needed to draw conclusions.Aliment Pharmacol Ther2016
27537685Tyrosinase-Cre-Mediated Deletion of the Autophagy Gene Atg7 Leads to Accumulation of the RPE65 Variant M450 in the Retinal Pigment Epithelium of C57BL/6 Mice.PLoS One2016
25496309SQSTM1/p62 regulates the expression of junctional proteins through epithelial-mesenchymal transition factors.Cell Cycle2015
25634357Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.J Invest Dermatol2015
25496309SQSTM1/p62 regulates the expression of junctional proteins through epithelial-mesenchymal transition factors.Cell Cycle2015
26307673A caveolin-dependent and PI3K/AKT-independent role of PTEN in β-catenin transcriptional activity.Nat Commun2015
26165517Paracrine Met signaling triggers epithelial-mesenchymal transition in mammary luminal progenitors, affecting their fate.Elife2015
26489459New Functional Signatures for Understanding Melanoma Biology from Tumor Cell Lineage-Specific Analysis.Cell Rep2015
26489459New Functional Signatures for Understanding Melanoma Biology from Tumor Cell Lineage-Specific Analysis.Cell Rep2015
26307673A caveolin-dependent and PI3K/AKT-independent role of PTEN in β-catenin transcriptional activity.Nat Commun2015
26165517Paracrine Met signaling triggers epithelial-mesenchymal transition in mammary luminal progenitors, affecting their fate.Elife2015
25634357Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.J Invest Dermatol2015
25173976Mammary stem cells have myoepithelial cell properties.Nat Cell Biol2014
25173976Mammary stem cells have myoepithelial cell properties.Nat Cell Biol2014
23712598Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal.Stem Cells2013
24312283Automated cell tracking and analysis in phase-contrast videos (iTrack4U): development of Java software based on combined mean-shift processes.PLoS One2013
24267888A polymorphism in IRF4 affects human pigmentation through a tyrosinase-dependent MITF/TFAP2A pathway.Cell2013
24171719Myc is required for β-catenin-mediated mammary stem cell amplification and tumorigenesis.Mol Cancer2013
23712598Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal.Stem Cells2013
24312283Automated cell tracking and analysis in phase-contrast videos (iTrack4U): development of Java software based on combined mean-shift processes.PLoS One2013
24171719Myc is required for β-catenin-mediated mammary stem cell amplification and tumorigenesis.Mol Cancer2013
24267888A polymorphism in IRF4 affects human pigmentation through a tyrosinase-dependent MITF/TFAP2A pathway.Cell2013
  • 1 - 50 of 90

Recommended Authors

Florent Dingli
Institut Curie, PSL Research University
Career Start Year 2011
Number of shared co-authors 0
Petra Sekyrova
Uppsala University
Career Start Year 2006
Number of shared co-authors 0
Prisca Liberali
Friedrich Miescher Institute for Biomedical Imaging
Career Start Year 2003
Number of shared co-authors 0
Susan L Woods
Adelaide Medical School, University of Adelaide
Career Start Year 2002
Number of shared co-authors 5
Vitezslav Bryja
Masaryk University
Career Start Year 2001
Number of shared co-authors 0
Heiko Blaser
Princess Margaret Cancer Centre
Career Start Year 2001
Number of shared co-authors 0
Qingxia Wei
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year 2000
Number of shared co-authors 0
David K Crossman
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 0
Stephane Angers
Department of Pharmaceutical Sciences, University of Toronto
Career Start Year 1999
Number of shared co-authors 0
Vivian Lee
Keck School of Medicine of USC, University of Southern
Career Start Year 1999
Number of shared co-authors 0
Kaylene J Simpson
The University of Melbourne, Peter MacCallum Cancer Centre
Career Start Year 1996
Number of shared co-authors 0
Damarys Loew
Institut Curie, PSL Research University
Career Start Year 1996
Number of shared co-authors 0
Alexander D Borowsky
University of California Davis Health
Career Start Year 1995
Number of shared co-authors 1
Karen H Martin
West Virginia University Cancer Institute, West Virginia University
Career Start Year 1993
Number of shared co-authors 0
Joseph Loureiro
Novartis Institutes for Biomedical
Career Start Year 1993
Number of shared co-authors 0
Marcus Bosenberg
Yale School of Medicine
Career Start Year 1992
Number of shared co-authors 8
Ashani T Weeraratna
Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine
Career Start Year 1992
Number of shared co-authors 8
Senthil K Muthuswamy
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1992
Number of shared co-authors 0
Roger Chammas
Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo
Career Start Year 1989
Number of shared co-authors 0
Dirk Geerts
Amsterdam University Medical Center
Career Start Year 1989
Number of shared co-authors 0
Melissa H Wong
Oregon Health & Science University
Career Start Year 1988
Number of shared co-authors 0
Rainer Heuchel
Karolinska Institutet
Career Start Year 1988
Number of shared co-authors 0
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
Jeffrey L Wrana
Lunenfeld-Tanenbaum Research Institute Mount Sinai Hospital
Career Start Year 1985
Number of shared co-authors 0
Hans Clevers
Princess Maxima Center for Pediatric Oncology
Career Start Year 1985
Number of shared co-authors 1
Anthony E Oro
Stanford University
Career Start Year 1985
Number of shared co-authors 0
Jorge Silvio Gutkind
Moores Cancer Center, University of California San Diego
Career Start Year 1984
Number of shared co-authors 4
Simon C Watkins
Center for Molecular Imaging, University of Pittsburgh School of Medicine
Career Start Year 1981
Number of shared co-authors 0
David J Adams
Wellcome Sanger Institute
Career Start Year 1980
Number of shared co-authors 7
Elaine Fuchs
The Rockefeller University
Career Start Year 1976
Number of shared co-authors 5

Collaborators

Lionel Larue
Institut Curie, PSL Research University, INSERM U1021
Co-authored papers 19
Robert A Cornell
University of Iowa
Co-authored papers 3
Stuart J Gallagher
Co-authored papers 3
Eir??kur Steingr??msson
BioMedical Center, University of Iceland
Co-authored papers 3
Jos Jonkers
Oncode Institute, Netherlands Cancer Institute
Co-authored papers 2
Eric Van Otterloo
College of Dentistry & Dental Clinics, University of Iowa
Co-authored papers 2
Richard A Sturm
Frazer Institute, The University of Queensland, Dermatology Research Centre
Co-authored papers 1
Agnar Helgason
University of Iceland
Co-authored papers 1
Aaron G Smith
Dermatology Research Centre, UQ Diamantina Institute, The University of Queensland
Co-authored papers 1
David U Gorkin
Center for Epigenomics, University of California San Diego
Co-authored papers 1
Andrew E Aplin
Thomas Jefferson University
Co-authored papers 1
Theresa Guo
Moores Cancer Center, University of California
Co-authored papers 1
Stacie K Loftus
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 1
Andreas Pollreisz
Medical University of Vienna
Co-authored papers 1
Ursula Schmidt-Erfurth
Medical University of Vienna
Co-authored papers 1
Andrew S McCallion
Johns Hopkins University School of Medicine
Co-authored papers 1
Colin R Goding
Ludwig Institute for Cancer Research, University of Oxford
Co-authored papers 1
Erna Magn??sd??ttir
University of Iceland
Co-authored papers 1
Alexander M Metcalf
Queensland Institute of Medical Research
Co-authored papers 1
Margret H Ogmundsdottir
Biomedical Center, University of Iceland
Co-authored papers 1
Glenn Merlino
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
William J Pavan
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 1
Kathleen C Robinson
Massachusetts General Hospital, Harvard Medical School
Co-authored papers 1
Martin I Sigurdsson
Landspitali University Hospital, University of Iceland
Co-authored papers 1
Mona Shehata
University of Cambridge
Co-authored papers 1
Christian Praetorius
Center for Regenerative Therapies, Technical University Dresden
Co-authored papers 1
Simon N Stacey
deCODE genetics/Amgen Inc.
Co-authored papers 1
Sean Davis
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 1
Ulduz Sobhiafshar
Bogazici University, Center for Life Sciences and Technologies
Co-authored papers 1
Fabrice P Cordelières
Co-authored papers 1
Release 1.2